Growth Metrics

Bruker (BRKR) Equity Average (2016 - 2025)

Bruker (BRKR) has disclosed Equity Average for 15 consecutive years, with $2.5 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Equity Average rose 35.44% year-over-year to $2.5 billion, compared with a TTM value of $2.5 billion through Dec 2025, up 35.44%, and an annual FY2025 reading of $2.1 billion, up 33.27% over the prior year.
  • Equity Average was $2.5 billion for Q4 2025 at Bruker, up from $2.1 billion in the prior quarter.
  • Across five years, Equity Average topped out at $2.5 billion in Q4 2025 and bottomed at $966.2 million in Q3 2022.
  • Average Equity Average over 5 years is $1.4 billion, with a median of $1.2 billion recorded in 2023.
  • The sharpest move saw Equity Average fell 8.2% in 2022, then soared 46.59% in 2024.
  • Year by year, Equity Average stood at $1.1 billion in 2021, then fell by 4.62% to $1.0 billion in 2022, then increased by 26.43% to $1.3 billion in 2023, then surged by 38.16% to $1.8 billion in 2024, then soared by 35.44% to $2.5 billion in 2025.
  • Business Quant data shows Equity Average for BRKR at $2.5 billion in Q4 2025, $2.1 billion in Q3 2025, and $1.8 billion in Q2 2025.